SCHEMBL85631

SCHEMBL85631

COCCOS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
LMNA P02545 2/20 0.50
HPGD P15428 2/20 0.50
HTT P42858 1/20 0.50
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA9 Q16790 2/20 0.48
GAA P10253 2/20 0.45
STAT3 P40763 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA2 P00918 1/20 0.42
CA3 P07451 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
MAPT P10636 2/20 0.41
VDR P11473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL9985962 0.98 ALDH1A1 (0.49) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL40774 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL361530 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL2329512 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL18998977 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL25398474 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL1218220 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL21877144 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL22262524 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12
SCHEMBL8282614 0.95 ALDH1A1 (0.47) ALDH1A1LMNAHPGDHTTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 770 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059883-A Production and preparation method of erlotinib intermediate 安徽尖峰北卡药业有限公司 2026-05-19 CN claimed
CN-116836389-B Low-temperature-curable positive photosensitive resin, resin composition, preparation method and application thereof 明士(北京)新材料开发有限公司 2024-01-26 CN claimed
CN-115108999-B Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application 暨南大学 2023-11-03 CN claimed
CN-116836389-A Low-temperature-curable positive photosensitive resin, resin composition, preparation method and application thereof 明士(北京)新材料开发有限公司 2023-10-03 CN claimed
CN-115057762-B Aggregation-resistant induced quenching type rigid Gemini fluorescent amphiphilic molecule and synthesis method thereof 武汉大学 2023-09-08 CN claimed
CN-114835765-B Synthesis process of 2' -O- (2-methoxyethyl) guanosine 奥锐特药业(天津)有限公司 2022-11-08 CN claimed
CN-115108999-A Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application 暨南大学 2022-09-27 CN claimed
CN-115057762-A Aggregation-induced quenching-resistant rigid Gemini fluorescent amphiphilic molecule and synthesis method thereof 武汉大学 2022-09-16 CN claimed
CN-114835765-A 2 a , Synthesis process of (E) -O- (2-methoxyethyl) guanosine 奥锐特药业(天津)有限公司 2022-08-02 CN claimed
CN-114213637-A Synthetic method of high-molecular-weight polylactic acid 江苏睿安应用生物技术股份有限公司 2022-03-22 CN claimed
CN-105461708-A Quinazoline tyrosine kinase inhibitor, and preparation method and application thereof SHANGHAI SUN-SAIL PHARMACEUTICAL SCIENCE & TECH CO LTD 2016-04-06 CN claimed
CN-104177351-B A kind of ratio method surveys fluorescent probe reagent and the Synthesis and applications of Ag+, F-or AcO- GUIZHOU UNIVERSITY (CN) 2016-03-09 CN claimed
CN-105367805-A H2O2-responded fluorescent single-molecule conjugated polymer and micelle, preparation method and application thereof UNIV SHANGHAI JIAOTONG 2016-03-02 CN claimed
US-20150348662-A1 PROCESS AND APPARATUS FOR SEPARATION OF TECHNETIUM-99M FROM MOLYBDATE The Governors of the University of Alberta, The University of British Columbia, Carleton Unive (CA) 2015-12-03 US claimed
CN-103342699-B A kind of tonka bean camphor-thia cup [4] aromatic hydrocarbons fluorescent reagent and its preparation method and application GUIZHOU UNIVERSITY (CN) 2015-08-26 CN claimed
CN-104177351-A Fluorescent probe reagent for measuring Ag<+>, F<-> or AcO<-> by use of ratio method, and preparation method and application of fluorescent probe reagent UNIV GUIZHOU 2014-12-03 CN claimed
US-20140213777-A1 LUMINESCENT PROBES FOR BIOLOGICAL LABELING AND IMAGING, AND PROCESS FOR PREPARING THE SAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-07-31 US claimed
WO-2014097269-A1 PROCESS AND APPARATUS FOR SEPARATION OF TECHNETIUM-99M FROM MOLYBDATE THE GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE UNIVERSITY OF BRITISH COLUMBIA, CARLETON UNIVERSITY, SIMON FRASER UNIVERSITY, THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO AND THE UNIVERSITY OF VICTORIA, collectively carrying on business as TRIUMF (CA) 2014-06-26 WO claimed
CN-103342699-A Coumarin-thiacalix [4] arene fluorescent reagent as well as preparation method and application thereof UNIV GUIZHOU 2013-10-09 CN claimed
CN-102443128-A Method for preparing polyurethane material grafted by methoxy polyethylene glycol UNIV SOUTHEAST 2012-05-09 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213777-A1 LUMINESCENT PROBES FOR BIOLOGICAL LABELING AND IMAGING, AND PROCESS FOR PREPARING THE SAME SLC30A6, SLC30A7, SLC39A7 ALDH1A1 2243/4885LMNA 403/4885HPGD 2292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.